Literature DB >> 16918095

Cancer-related breakthrough pain.

Andrew N Davies1.   

Abstract

Breakthrough pain is a common problem in patients with cancer, and is associated with significant morbidity among this group of patients. This review examines the different types of breakthrough pain, and the various options for the management of breakthrough pain.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16918095     DOI： 10.12968/hmed.2006.67.8.21960

Source DB:  PubMed          Journal:  Br J Hosp Med (Lond)        ISSN： 1750-8460            Impact factor:   0.825


  3 in total

1.  Formulation selection and pharmacokinetic comparison of fentanyl buccal soluble film with oral transmucosal fentanyl citrate: a randomized, open-label, single-dose, crossover study.

Authors:  Niraj Vasisht; Larry N Gever; Ignacio Tagarro; Andrew L Finn
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

2.  Development and performance of a diagnostic/prognostic scoring system for breakthrough pain.

Authors:  Boaz Gedaliahu Samolsky Dekel; Marco Palma; Maria Cristina Sorella; Alberto Gori; Alessio Vasarri; Rita Maria Melotti
Journal:  J Pain Res       Date:  2017-05-31       Impact factor: 3.133

3.  Efficacy, safety, and tolerability of sublingual fentanyl orally disintegrating tablet in the treatment of breakthrough cancer pain: a randomized, double-blind, placebo-controlled study.

Authors:  Masoud Hashemi; Alireza Zali; Ebrahim Golmakani; Mohammad Hossein Delshad; Mahdi Shadnoush; Mohammad-Esmaeil Akbari
Journal:  Daru       Date:  2021-01-21       Impact factor: 3.117
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.